Latest Updates /  Capital Markets

Adv. Micky Barnea was interviewed by Globes regarding the US Securities and Exchange Commission’s proposal to tighten the criteria for foreign private issuers — a move that could affect around 100 Israeli companies currently traded in the US. These companies benefit from significant regulatory exemptions, including relief from filing quarterly reports and less stringent executive compensation disclosures. While the proposal primarily targets Chinese issuers, the implications for Israeli companies may be substantial, both in terms of regulatory burden and cost.

Adv. Ilan Blumenfeld, Partner and Head of our Israeli Commercial Practice in the firm's corporate department, delivered a lecture on “The Legal Aspects of Mergers and Acquisitions: Preparing a Company for Sale and/or Merger” as part of the CFO training program organized by the Manufacturers Association of Israel (MAI).

 We are holding a Practical and focused webinar with GCs for GCs, Led by Adv. Hagit Ross and Adv. Omri Oren, partners in the firm's Capital Markets Department.  The session will provide clear guidelines for building an effective compensation policy – including best practices for structure, mandatory components, and key considerations from regulatory, legal, and market perspectives that should inform the decision-making process. We will also take a close look at the special grant: when it is appropriate to include one, the rationale and circumstances for doing so, and how to best integrate it into the overall compensation framework – with a particular focus on the Israel Securities Authority’s current position and applicable legal requirements.

Shortly before former President Donald Trump announced a 90-day freeze on tariffs affecting most of the U.S.’s trade partners—sending global markets soaring—he published a series of controversial posts referencing the ticker of a company he owns. These posts raised serious legal questions regarding potential market manipulation, conflicts of interest, and regulatory exposure. Dr. Zvi Gabbay shared his legal insights in an interview with N12.  

Israel’s financial landscape has recently faced significant shocks. With capital markets experiencing notable declines, the question arises: what does this mean for real estate? Adv. Alon Wolner, a partner in our Real Estate Department, spoke to TheMarker about how the current capital market volatility is influencing real estate investment trends in Israel and the key challenges developers are now facing.

Yozmot - Real Estate Development, an entrepreneurial contracting company specializing in urban renewal, has successfully completed its inaugural bond issuance and is now listed on the Tel Aviv Stock Exchange, raising approximately NIS 50 million. The offering was supported by Advs. Elad Reshtick from our firm's Capital Markets Department.

Adv. Dr. Zvi Gabbay, Head of our Regulation Department, has been invited to join an expert panel on "Best Practices for Fintech Implementation and Operations" at the Fintech-Tel Aviv 2025 Annual Summit! Startups, investors, and companies are invited to this unique fintech event. 

Adv. Omri Oren, Partner in the Finance and Public Corporations Department at our firm, along with Advs. Raz Landau and Batel Torangi, advised "Mediterranean Towers Ltd" Group in the issuance of a new series of bonds amounting to approximately NIS 200 million. The company received strong demand during the institutional offering phase, with demand reaching approximately NIS 684 million.